Psycheceutical Bioscience Stock

Psycheceutical Bioscience FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Psycheceutical Bioscience (BWVI) as of Sep 10, 2026 is 20.39 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 61.48 % — a change of -66.84% (lower).

FCF Conversion

20.39 %

YoY

-66.84%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Psycheceutical Bioscience is 2026 20.39 % . FCF Conversion Rate (FCF/EBITDA) of Psycheceutical Bioscience was 2025 61.48 % . It decreases by -66.84% lower compared to the previous year.

The Psycheceutical Bioscience FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2015
38.63 USD
Jan 1, 2016
37.79 USD
Jan 1, 2017
49.15 USD
Jan 1, 2018
41.02 USD
Jan 1, 2019
76.30 USD
Jan 1, 2020
30.33 USD
Jan 1, 2021
61.48 USD
Jan 1, 2022
20.39 USD
The Psycheceutical Bioscience FCF Conversion history
YEARFCF ConversionYoY
20.39 %-66.84%
61.48 %+102.71%
30.33 %-60.25%
76.30 %+86.00%
41.02 %-16.53%
49.15 %+30.04%
37.79 %-2.16%
38.63 %-13.82%
44.82 %
Access this data via the Eulerpool API

Psycheceutical Bioscience Stock analysis

What does Psycheceutical Bioscience do? Blue Water Ventures International Inc (BWVI) is a company specialized in the exploration of treasures on the seabed. The company's history dates back to 2005 when founder Keith Webb had the idea to search for lost treasures at sea. Since then, BWVI has become a leading company in the industry. BWVI's business model is based on treasure hunting at sea. The company uses state-of-the-art technologies to locate shipwrecks and other treasures on the ocean floor. Once a treasure is discovered, BWVI forms partnerships with other companies to recover and market the treasure. The profits from the sale of the treasure are divided between BWVI and its partners. BWVI also owns and operates its own online auction where antiques such as jewelry, historical coins, and artifacts are exhibited and sold. The auction is an important part of BWVI's business model and offers customers the opportunity to acquire unique treasures. The company has various divisions all focused on underwater treasure hunting. One division focuses on the exploration and search for sunken ships and artifacts. Another division focuses on the exploration of sites where potential treasures are suspected. BWVI utilizes state-of-the-art technologies such as sonar and magnetic sensors to locate underwater treasures. BWVI also offers services such as archiving and restoration of artifacts. The company collaborates with experts to ensure the best possible preservation and restoration of historical artifacts. BWVI's portfolio includes a variety of products and services. These include unique treasures such as jewels, gold and silver coins, ceramics, and other artifacts recovered from historical shipwrecks. Additionally, the company also offers merchandising items such as t-shirts, caps, and keychains featuring the BWVI logo. Recently, BWVI has also begun to explore other business areas. The company has partnered with a CBD product manufacturer and will be bringing CBD products to the market. Furthermore, BWVI has plans to enter the field of renewable energies, particularly tidal power plants. Overall, BWVI has undergone an impressive development in recent years. The company has established itself as a leading player in underwater treasure hunting and offers its customers a unique experience. With a strong portfolio of products and services and a clear vision for the future, BWVI is well-positioned to continue its success in the future. Psycheceutical Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Psycheceutical Bioscience stock

FCF Conversion Rate (FCF/EBITDA) of Psycheceutical Bioscience is 20.39 % in 2026.

FCF Conversion Rate (FCF/EBITDA) of Psycheceutical Bioscience changed from 61.48 % to 20.39 %, representing a -66.84% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Psycheceutical Bioscience since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Psycheceutical Bioscience with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

Cash Flow — Psycheceutical Bioscience

All Key Metrics — Psycheceutical Bioscience